Condensed Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Distributions in Excess of Accumulated Net Income	Accumulated Comprehensive Income
Balance beginning of period (in shares) at Dec. 31, 2022		67,472,553
Balance beginning of period at Dec. 31, 2022	$ 1,603,909	$ 67	$ 5,456,968	$ (3,879,847)	$ 26,721
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,133			1,133
Unrealized gain (loss) on derivatives	(3,317)				(3,317)
Reclassification to interest expense, net	(2,892)				(2,892)
Distributions declared	(14,548)			(14,548)
Stock-based compensation, net (in shares)		36,088
Stock-based compensation, net	2,120	$ 1	2,119
Balance end of period (in shares) at Mar. 31, 2023		67,508,641
Balance end of period at Mar. 31, 2023	$ 1,586,405	$ 68	5,459,087	(3,893,262)	20,512
Balance beginning of period (in shares) at Dec. 31, 2023	67,807,831	67,807,831
Balance beginning of period at Dec. 31, 2023	$ 1,554,044	$ 68	5,468,728	(3,932,826)	18,074
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,900			2,900
Unrealized gain (loss) on derivatives	7,319				7,319
Reclassification to interest expense, net	(3,317)				(3,317)
Distributions declared	(15,360)			(15,360)
Stock-based compensation, net (in shares)		66,697
Stock-based compensation, net	$ 2,463		2,463
Balance end of period (in shares) at Mar. 31, 2024	67,874,528	67,874,528
Balance end of period at Mar. 31, 2024	$ 1,548,049	$ 68	$ 5,471,191	$ (3,945,286)	$ 22,076